期刊
ONCOGENE
卷 31, 期 9, 页码 1166-1175出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2011.302
关键词
ceramide; sphingosine-1-phosphate; p53; sphingosine kinase; cancer; senescence
资金
- Biomedical Laboratory Research and Development Service of the VA Office of Research and Development [I01BX000156]
- NIH/NIGMS [R01 GM062887]
- NIH/NCI [P01 CA097132-project 3, P01 CA097132-project 1]
- American Heart Association [AHA 081509E]
- NIH MSTP [GM08716]
- MUSC Hollings Cancer Center Abney Foundation
- NIH/NIEHS [T32 ES012878, F30ES017379]
- NCI [IPO1CA097132, P30 CA 138313]
- NIH/NCRR SC COBRE [P20 RR017677]
- NIH [C06 RR018823]
- National Center for Research Resources
p53 is a crucial tumor suppressor that is mutated or deleted in a majority of cancers. Exactly how p53 prevents tumor progression has proved elusive for many years; however, this information is crucial to define targets for chemotherapeutic development that can effectively restore p53 function. Bioactive sphingolipids have recently emerged as important regulators of proliferative, apoptotic and senescent cellular processes. In this study, we demonstrate that the enzyme sphingosine kinase 1 (SK1), a critical enzyme in the regulation of the key bioactive sphingolipids ceramide, sphingosine and sphingosine-1-phosphate (S1P), serves as a key downstream target for p53 action. Our results show that SK1 is proteolysed in response to genotoxic stress in a p53-dependent manner. p53 null mice display elevation of SK1 levels and a tumor-promoting dysregulation of bioactive sphingolipids in which the anti-growth sphingolipid ceramide is decreased and the pro-growth sphingolipid S1P is increased. Importantly, deletion of SK1 in p53 null mice completely abrogated thymic lymphomas in these mice and prolonged their life span by similar to 30%. Deletion of SK1 also significantly attenuated the formation of other cancers in p53 heterozygote mice. The mechanism of p53 tumor suppression by loss of SK1 is mediated by elevations of sphingosine and ceramide, which in turn were accompanied by increased expression of cell cycle inhibitors and tumor cell senescence. Thus, targeting SK1 may restore sphingolipid homeostasis in p53-dependent tumors and provide insights into novel therapeutic approaches to cancer. Oncogene (2012) 31, 1166-1175; doi:10.1038/onc.2011.302; published online 18 July 2011
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据